Breakthrough Research in Single Ventricle Disease Provides Insights into Pediatric Heart Failure
Breakthrough science often begins with asking difficult clinical questions. Recent research by Dr. James F. Martin, Director of the Cardiomyocyte...
Breakthrough science often begins with asking difficult clinical questions. Recent research by Dr. James F. Martin, Director of the Cardiomyocyte...
At The Texas Heart Institute at Baylor College of Medicine, advancing cardiovascular science is central to our mission, and the...
Breakthrough YAP101 therapy advances to next phase following positive safety review The Texas Heart Institute at Baylor College of Medicine...
The Texas Heart Institute at Baylor College of Medicine’s Gene Editing Lab has been awarded a highly competitive NIH R01...
Demonstrating its continued commitment to innovation in cardiovascular science and medicine, The Texas Heart Institute recently hosted the 11th Annual...
Novel Discovery and Milestone in Cardiac Research Revealed in Nature Cardiovascular Research HOUSTON (February 14, 2024) – A groundbreaking scientific study...
Revolutionary Genomic Study Sheds Light on Immune Microenvironment in Transplanted Pediatric Hearts HOUSTON (February 12, 2024) – Pediatric heart transplantation has...
Researchers at The Texas Heart Institute, Baylor College of Medicine (BCM), and YAP Therapeutics have recently shown that gene therapy...
Altmetrics Attention Scores reveal the most popular articles from The Texas Heart Institute in 2022 The impact of a scientific...
Physician scientist James F. Martin, MD, PhD, Director of the Cardiomyocyte Renewal Laboratory at The Texas Heart Institute and Vice...
Our Professional Staff members have demonstrated a commitment to advancing cardiovascular science. This can be seen in their research output....
During its annual day-long Research Symposium on October 20, 2022, The Texas Heart Institute community came together in the Denton...